NeuroPace Reports Strong Q2 Results and Raises 2023 Outlook
NeuroPace, a commercial-stage medical device company, experienced a surge in its stock price, with shares advancing by 13% to $4.65 ...
Tag: 2023 outlook
Northrop Grumman Corp. Beats Revenue and Earnings Target, Raises 2023 Outlook
Northrop Grumman Corp. (NOC) stock saw a 0.8% increase in premarket trades on Thursday following the defense contractor's impressive second-quarter ...
